Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis

Background/Aims: There are no data regarding the association between sarcopenic obesity status and nonalcoholic fatty liver disease (NAFLD) and NAFLD-associated liver fibrosis. Therefore, we aimed to investigate the relationship between sarcopenic obesity status (sarcopenia only, obesity only, and s...

Bibliografske podrobnosti
Main Authors:	Wolhwa Song, Sung Hwan Yoo, Jinsun Jang, Su Jung Baik, Byoung Kwon Lee, Hyun Woong Lee, Jong Suk Park
Format:	Article
Jezik:	English
Izdano:	Gastroenterology Council for Gut and Liver 2023-01-01
Serija:	Gut and Liver
Teme:	obesity non-alcoholic fatty liver disease liver fibrosis
Online dostop:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl220041

Podobne knjige/članki

Risk Factors of Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Non-Obese Patients with Obstructive Sleep Apnea
od: Lian N, et al.
Izdano: (2022-12-01)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
od: Dae Ho Lee
Izdano: (2020-06-01)

Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
od: Do Seon Song, et al.
Izdano: (2019-11-01)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
od: Jung Hwan Yu, et al.
Izdano: (2023-02-01)

Comparison of Transient Elastography and Liver Biopsy in Assessing Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
od: Gaurav Bachhav, et al.
Izdano: (2021-05-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
od: Gwyneth Shook Ting Soon, et al.
Izdano: (2021-01-01)

Transaminases and gamma glutamyl transpeptidase for detecting nonalcoholic steatohepatitis and fibrosis in nonalcoholic fatty liver disease
od: Shahinul Alam, et al.
Izdano: (2016-07-01)

Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease
od: Tatsuya Hayashi, et al.
Izdano: (2017-09-01)

The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease
od: A. S. Kuznetsova, et al.
Izdano: (2023-01-01)

Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
od: Yu.M. Stepanov, et al.
Izdano: (2017-09-01)

Diagnostic Performance of Serum Asialo-α1-acid Glycoprotein for Advanced Liver Fibrosis or Cirrhosis in Patients with Chronic Hepatitis B or Nonalcoholic Fatty Liver Disease
od: Seung Up Kim, et al.
Izdano: (2019-12-01)

Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
od: Da Hea Seo, et al.
Izdano: (2022-07-01)

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
od: Eda Kaya, et al.
Izdano: (2020-07-01)

Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
od: Sang Yi Moon, et al.
Izdano: (2024-03-01)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
od: Jong Hwa Choi, et al.
Izdano: (2020-10-01)

Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States
od: Yuanhui Guo, et al.
Izdano: (2023-09-01)

Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital
od: Jaejun Lee, et al.
Izdano: (2023-09-01)

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
od: Ma Ai Thanda Han
Izdano: (2020-09-01)

ALS-L1023 from <i>Melissa officinalis</i> Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model
od: Eun Jeoung Lee, et al.
Izdano: (2022-12-01)

Identification of high-risk subjects in nonalcoholic fatty liver disease
od: Christiane Stern, et al.
Izdano: (2023-02-01)

Role of mast cells in the pathogenesis of liver fibrosis in nonalcoholic fatty liver disease
od: Ewa Lewandowska, et al.
Izdano: (2020-05-01)

Risk predictors of advanced hepatic fibrosis in patients with nonalcoholic fatty liver disease – a survey in a university hospital in Brazil
od: Thaís Grecca Andrade, et al.
Izdano: (2022-10-01)

CHANGES IN FIBROSIS UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADEMETHYANINIUM AND ARGININE GLUTAMATE
od: N.R. Matkovska
Izdano: (2020-11-01)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
od: Yuna Kim, et al.
Izdano: (2022-03-01)

Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
od: Sangsoo Han, et al.
Izdano: (2022-11-01)

Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
od: Diaz Soto MP, et al.
Izdano: (2020-08-01)

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
Izdano: (2013-05-01)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
od: Chanbin Lee, et al.
Izdano: (2019-10-01)

Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
od: Akash Roy, et al.
Izdano: (2024-09-01)

Non-Alcoholic Fatty Liver Disease and the Risk of Liver Fibrosis in Chronic Hepatitis B Patients
od: Andri Sanityoso Sulaiman, et al.
Izdano: (2023-09-01)

Non-alcoholic fatty liver disease: Definition and subtypes
od: Seul Ki Han, et al.
Izdano: (2023-02-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
od: Yuya Seko, et al.
Izdano: (2020-10-01)

Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease
od: José Tadeu Stefano, et al.
Izdano: (2021-01-01)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
od: Maamon Basheer, et al.
Izdano: (2023-04-01)

The Association between Educational Attainment and the Risk of Nonalcoholic Fatty Liver Disease among Chinese Adults: Findings from the REACTION Study
od: Yuanyue Zhu, et al.
Izdano: (2024-07-01)

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
od: Seul Ki Han, et al.
Izdano: (2023-07-01)

Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
Izdano: (2014-05-01)

Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
od: Inbeom Kwon, et al.
Izdano: (2019-05-01)

Nonalcoholic fatty liver disease burden – Switzerland 2018–2030
od: Nicolas Goossens, et al.
Izdano: (2019-12-01)

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
od: Yiyoung Kwon, et al.
Izdano: (2022-04-01)